MIRA Pharmaceuticals, Inc. (MIRA)
Recent Filing Index
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Cover | ||
| Statements | ||
| Balance Sheets | ||
| Consolidated Balance Sheets | ||
| Balance Sheets (P) | ||
| Consolidated Balance Sheets (P) | ||
| Consolidated Statements of Operations | ||
| Statements of Operations | ||
| Codensed Consolidated Statements of Changes In Stockholders' Equity (unaudited) | — |
|
| Condensed Consolidated Statements of Changes In Stockholders' Equity (unaudited) | — |
|
| Condensed Statements of Changes In Stockholders' Equity (unaudited) | — |
|
| Condensed Statements of Stockholders' Equity (deficit) (unaudited) | — |
|
| Consolidated Statements of Changes In Stockholders' Equity(deficit) | — |
|
| Statements of Changes In Stockholders' Equity (deficit) | — |
|
| Statements of Stockholders' Equity | ||
| Consolidated Statements of Cash Flows | ||
| Consolidated Statements of Changes In Stockholders' Equity(deficit) (P) | — |
|
| Statements of Cash Flows | ||
| Statements of Cash Flows (P) | ||
| Notes | ||
| Accounts Payable and Accrued Liabilities | ||
| Asset Acquisition | ||
| Asset Acquisition and Short-term Investment | — |
|
| Commitments and Contingencies | ||
| Cybersecurity Risk Management and Strategy Disclosure | — |
|
| Debt, Related Party | ||
| Description of Business and Summary of Significant Accounting Policies | ||
| Description of Business and Summary of Significant Accounting Policies: | — |
|
| Employment Agreements | ||
| Going Concern | ||
| Income Taxes | — |
|
| Insider Trading Arrangements | — |
|
| Insider Trading Policies and Procedures | — |
|
| Leases | ||
| License Agreement, Related Party | ||
| Line of Credit, Related Party | — |
|
| Liquidity and Capital Resources | ||
| Pay Vs Performance Disclosure | — |
|
| Prepaid Expenses | ||
| Related Party Transactions | ||
| Segment Information | ||
| Stockholders Equity | ||
| Subsequent Events | ||